Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells

Li, XY; Yuan, X; Wang, ZM; Li, J; Liu, ZW; Wang, YK; Wei, LM; Li, YP; Wang, XS

Wang, XS (通讯作者),Henan Univ Sci & Technol, Henan Key Lab Canc Epigenet, Canc Hosp, Affiliated Hosp 1,Coll Clin Med,Med Coll, Luoyang, Peoples R China.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

Poly (ADP-ribose) polymerase inhibitor (PARPi) resistance is a new challenge for antitumor therapy. The purpose of this study was to investigate the r......

Full Text Link